Cargando…

International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B

Detalles Bibliográficos
Autores principales:	Marcovina, Santica, Curtiss, Linda K., Milne, Ross, Albers, John J.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2547832/ https://www.ncbi.nlm.nih.gov/pubmed/18925274 http://dx.doi.org/10.1155/S1463924690000256

Ejemplares similares

International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Enzymes. IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine (N-phosphotransferase, EC 2.7.3.2). IFCC Recommendation
por: Hørder, M., et al.
Publicado: (1990)

International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on pH, Blood Gases and Electrolytes: Guidelines for Transcutaneouspo(2)andpco(2) Measurement
por: Wimberley, P. D., et al.
Publicado: (1989)

Request for Nominations for Members for the Committee on Laboratory Management of the Education and Management Division of IFCC
por: Wilkinson, I.
Publicado: (2003)

Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
por: Clark, Justin R., et al.
Publicado: (2022)

Recommendation on Reporting Results for Blood Glucose (From an IFCC Stage 1 Document) IFCC Scientific Division Working Group on Selective Electrodes
por: Fogh-Andersen, Niels, et al.
Publicado: (2000)

International Federation of Clinical Chemistry (IFCC) Education Division, Expert Panel of Quantities and Units: A Protocol for the Conversion of Clinical Laboratory data
por: Lehmann, H. P., et al.
Publicado: (1989)

International Federation of Clinical Chemistry and Laboratory Medicine: SCIENTIFIC DIVISION COMMITTEE ON NOMENCLATURE, PROPERTIES AND UNITS (C-NPU)# and INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION(VII) § Project number 2001-059-1-700: PROPERTIES AND UNITS FOR TRANSFUSION MEDICINE AND IMMUNOHAEMATOLOGY (Technical report) (IFCC-IUPAC 2003)
por: VARMING, KIM, et al.
Publicado: (2004)

Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
por: Marcovina, Santica M., et al.
Publicado: (2022)

Guidelines (1987) for classification, calculation and validation of conversion rates in clinical chemistry – International Federation of Clinical Chemistry, Scientific Committee, Analytical Section: Expert Panel on Analytical Systems, Expert Panel on Enzymes; IFCC Document Stage 2, Draft 4
por: Bechtler, G., et al.
Publicado: (1987)

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
por: Parish, Sarah, et al.
Publicado: (2018)

IFCC News
Publicado: (2000)

A Progress Report of the IFCC Committee for Standardization of Thyroid Function Tests
por: Thienpont, Linda M., et al.
Publicado: (2014)

IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation
Publicado: (1999)

Standardized immunoprecipitation protocol for efficient isolation of native apolipoprotein E particles utilizing HJ15.4 monoclonal antibody
por: O’Leary, Justin, et al.
Publicado: (2023)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
por: Chan, Dick C., et al.
Publicado: (2019)

Apolipoprotein E Antibodies Affect the Retention of Passive Avoidance Memory in the Chick
por: Lancashire, Chris, et al.
Publicado: (1998)

IFCC Professional Scientific Exchange Programme: Paroxonase and its Role in Cardiovascular Disease
por: Frank, Elizabeth A
Publicado: (2001)

IFCC Professional Scientific Exchange Programme Report - Biochemical Markers of Bone Turnover
por: Cekovska, Svetlana
Publicado: (2001)

Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice
por: Brito, Victor, et al.
Publicado: (2017)

The effect of apolipoprotein A-I and perfluorocarbon emulsion on the production of specific antibodies in mice
por: Zhalimov, Vitaly, et al.
Publicado: (2021)

Apolipoprotein M
por: Luo, Guanghua, et al.
Publicado: (2004)

Apolipoproteins and cancer
por: Ren, Liwen, et al.
Publicado: (2019)

The IFCC Curriculum - phase 1
por: Greaves, Ronda F., et al.
Publicado: (2018)

Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness
por: Huang, Fei, et al.
Publicado: (2013)

Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus
por: Ahmed, Mohammed Mahmoud, et al.
Publicado: (2013)

Detection of circulating IgG antibodies to apolipoprotein B(100) in acute myocardial infarction
por: Zhang, Xueying, et al.
Publicado: (2015)

Apolipoproteins and Diabetic Retinopathy
por: Chait, Alan, et al.
Publicado: (2011)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Apolipoproteins and Alzheimer's pathophysiology
por: Koch, Manja, et al.
Publicado: (2018)

Association of apolipoprotein B, apolipoprotein A, and the its ratio with body fat distribution
por: Sadeghi, Masoumeh, et al.
Publicado: (2013)

Association of Ratio of Apolipoprotein B to Apolipoprotein A1 With Survival in Peritoneal Dialysis
por: Yu, Jing, et al.
Publicado: (2022)

The Association between Apolipoprotein A-II and Metabolic Syndrome in Korean Adults: A Comparison Study of Apolipoprotein A-I and Apolipoprotein B
por: Yi, Dong Won, et al.
Publicado: (2012)

Antibody Responses to Sarcoptes scabiei Apolipoprotein in a Porcine Model: Relevance to Immunodiagnosis of Recent Infection
por: Rampton, Melanie, et al.
Publicado: (2013)

Auto-antibodies against apolipoprotein A-1 block cancer cells proliferation and induce apoptosis
por: Satta, Nathalie, et al.
Publicado: (2020)

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)

The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
por: Kaneva, Anastasiya M., et al.
Publicado: (2015)

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019)

Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Meal-Related Changes in Apolipoprotein Particles After Treatment With an Antisense Oligonucleotide to Apolipoprotein CIII
por: Brite, Brianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mvjckpuoc3431k6avuk7v8fd22